Code No. | RN003P | |
Anti-EIF4G2 pAb | ||
Size | 200 µL (1 mg/mL) | |
Availability (in Japan) | 10 or more
(In Japan at 00:05, Apr 20, 2024 in JST) |
|
Clonality | Polyclonal | |
Clone | Polyclonal | |
Isotype (Immunized Animal) |
Rabbit Ig (aff.) | |
Applications | WB 1:1,000 IP 5 µg/250 µL of cell extract from 2.5 x 106 cells IC* reported. (PMID: 26990993) RIP 15 µg/500 µL of cell extract from 4.5 x 106 cells Other(eCLIP) reported. (PMID: 27018577) |
|
Immunogen (Antigen) |
KLH-conjugated synthetic peptide EVNPPSDETDSSSAPSKE (783-800 aa) | |
Reactivity [Gene ID] | ||
Storage buffer | 1 mg/mL in PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | eukaryotic translation initiation factor 4 gamma 2, OK/SW-cl.75, AAG1, DAP5, NAT1, P97 | |
Background | The eukaryote polypeptide chain initiation factor eIF4G forms complex with the mRNA cap-binding protein eIF4E and the ATP dependent RNA helicase eIF4A, constituting the initiation factor eIF4F complex. The eIF4G plays an important role in the mechanism of translation by tethering between other components of the ribosomal initiation factors. Two forms of eIF4G have been reported as two different gene products, eIF4G1 and 2. The eIF4G2 was identified as a functional homologue of eIF4G1. The homology of eIF4G2 to eIF4G1 is particularly high in central and carboxyl portions which corresponds to the eIF4A and eIF3 binding region. The proteolysis of both eIF4G1 and eIF4G2 is associated with a decrease in cell viability and the inhibition of protein synthesis. | |
Related products | RN1001 RIP-Assay Kit RN1005 RIP-Assay Kit for microRNA RN001P Anti-EIF4E pAb RN002P Anti-eIF4G1 (Human) pAb RN004M Anti-Ribosomal P0/P1/P2 mAb RN006M Anti-EIF4E mAb |
|
Product category | Research area:RNA-RNP Network Brands:RiboCluster Profiler™ |
|
Data | ||
Citations | Immunocytochemistry
Other(eCLIP)
|